Frequently Asked Question:
The market for Kidney Cancer/Renal Cell Carcinoma (RCC) Drugs Market is expected to reach USD$ 6,441.9 Mn in 2025.
The Kidney Cancer/Renal Cell Carcinoma (RCC) Drugs Market is expected to see significant CAGR growth over the coming years, at 8.1%.
The report is forecasted from 2017 -2025.
The base year of this report is 2016.
Active Biotech, Amgen, Bayer AG, Cipla Limited, F. Hoffmann-La Roche AG, Genentech, Inc., GlaxoSmithKline Plc, Novartis AG, Onyx, Pfizer, Inc. are some of the major players in the global market.